Reaction profile

The FDA adverse-event record for cranial nerve paralysis

14 FDA reports name cranial nerve paralysis, a lower-volume reaction in the CVM extract (VeDDRA 1150). Plate stamps and neighbourhood peers follow.

#2323 of 2,481
by report volume (all reactions)
14
reports citing this reaction
21.4%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Cranial nerve paralysis has 14 reports now versus 12 in that prior snapshot: 2 more (16.7%).

Report change
+2
Death-coded reports
+2
Death-coded share
+13.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Cranial nerve paralysis changes

FDA AER · VeDDRA plate

Code 1150 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 14 reports
  • DEATH-HOT 21.4%
  • BOTTOM-DECILE #2323/2481
  • PHOTO-FINISH Addisonian crisis
  • SPECIES-DOG Dog · 12
  • DRUG-LEAD Ivermectin + Pyra… · 2
  • DESK-WIDE 11 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Addisonian crisis (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Cranial nerve paralysis

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Addisonian crisis · near14Application site puru… · near14Bullous disorder NOS · near14Chapped skin · near14Cranial nerve paralys… · thi…14Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Cranial nerve paralysis

What the FDA AER plate says about Cranial nerve paralysis

Signature read: 14 reports place Cranial nerve paralysis in the lower third of FDA AER volume (#2323 of 2,481). Report volume is lower-third scale: 14 named reports in the openFDA extract. 3 of 14 reports were death-coded (21.4% of named reports, not a population mortality rate). Nearest volume peer: Addisonian crisis (±0 reports). Lead species Dog (12). Lead co-reported drug Ivermectin + Pyrantel (2).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Ivermectin + Pyrantel appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 12
Horse 1
Cat 1

Breeds Most Affected

Retriever - Labrador 3
Retriever - Golden 2
Paint 1
Crossbred Canine/dog 1
Terrier - West Highland White 1
Chihuahua 1
Shepherd (unspecified) 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Domestic Shorthair 1
Terrier - Bull - Miniature 1

Associated Drugs

Ivermectin + Pyrantel 2
Doxycycline 2
Gabapentin 2
Oxybendazole 1
Milbemycin Oxime + Spinosad 1
Fipronil 1
Fluralaner Chew Tablets 1
Canine B Burgdorferi *2 Alu Kb 1
Canine Lepto*4(Orig S-P Us) Kb 1
Canine Da2Ppv (Orig S-P Us) Lv 1
Milbemycin Oxime 1
Ivermectin 1
Afoxolaner 1
Sarolaner 1
Genta/Momet/Clotrim Ear Oint 1
Trilostane 1
Fluralaner Spot-On Solution 1
Carprofen 1
Leptospira Canicola L-15 Strain C-51;Leptospira Grippotyphosa 1550 Lot 10005 Str 1
Recombinant E. Coli Bl21;Recombinant E. Coli Ecl19 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Cranial nerve paralysis (#2323 of 2,481 by report volume); death-coded 21.4%. PlainBreed reaction plate · report volume stamp 14 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →